S&P 500

5.460,48

-0,41%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Anormed Ord (MM) (ANOR)
Anormed Ord (MM) (ANOR) Notícias

ANOR

Anormed Ord (MM) (ANOR)

Anormed Ord (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ANOR

1

Data	Hora	Fonte	Título	Código	Companhia
07/11/2006	19:57	PR Newswire (US)	Genzyme Completes Tender Offer for Outstanding Shares of AnorMED	NASDAQ:ANOR
07/11/2006	03:01	PR Newswire (US)	Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review	NASDAQ:ANOR
03/11/2006	02:05	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
26/10/2006	11:00	PR Newswire (US)	Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer	NASDAQ:ANOR	Anormed Ord (MM)
23/10/2006	11:00	PR Newswire (US)	AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule	NASDAQ:ANOR
17/10/2006	11:47	PR Newswire (US)	AnorMED and Genzyme reach agreement on acquisition	NASDAQ:ANOR
11/10/2006	23:03	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
11/10/2006	01:30	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
10/10/2006	11:50	PR Newswire (US)	Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash	NASDAQ:ANOR
06/10/2006	13:41	PR Newswire (US)	Genzyme Extends Deadline for Tender Offer to Acquire AnorMED Inc.	NASDAQ:ANOR	Anormed Ord (MM)
06/10/2006	00:10	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
05/10/2006	01:36	PR Newswire (US)	AnorMED board continues to recommend that shareholders accept Millennium's planned tender offer	NASDAQ:ANOR
26/09/2006	11:46	PR Newswire (US)	Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date	NASDAQ:ANOR
26/09/2006	11:45	PR Newswire (US)	AnorMED agrees to support a planned tender offer of US$12 per share from Millennium Pharmaceuticals	NASDAQ:ANOR
25/09/2006	02:23	PR Newswire (US)	Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
20/09/2006	11:00	PR Newswire (US)	AnorMED reports on Annual General Meeting	NASDAQ:ANOR
19/09/2006	09:30	PR Newswire (US)	AnorMED amends license agreement for cancer drug	NASDAQ:ANOR
19/09/2006	09:30	PR Newswire (US)	Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Cond	NASDAQ:ANOR
18/09/2006	11:00	PR Newswire (US)	Approval of FOSRENOL in Germany triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
15/09/2006	22:22	PR Newswire (US)	AnorMED Provides Update on Limited Duration Shareholder Rights Plan	NASDAQ:ANOR
12/09/2006	14:57	PR Newswire (US)	Atticus Capital LP Opposes Genzyme bid for AnorMED	NASDAQ:ANOR